LPTX - LEAP THERAPEUTICS, INC.
IEX Last Trade
2.94
0.005 0.170%
Share volume: 489
Last Updated: Thu 26 Dec 2024 08:29:27 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$2.94
0.00
0.17%
Summary score
29%
Profitability
43%
Dept financing
15%
Liquidity
50%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-17.81%
Return on assets
-38.97%
Return on sales
0%
Return on invested capital
180.11%
Total debt ratio
50.6%
Debt ratio change over timeo
-0.81%
Current Ratio
4.04%
Quick Ratio
0%
Cash Position Ratio
3.65%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
101.2%
Return on assets
-59.39%
Return on sales
0%
Return on invested capital
154.36%
Total debt ratio
65.29%
Debt ratio change over timeo
-0.6%
Current Ratio
3.81%
Quick Ratio
0%
Cash Position Ratio
3.74%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-10.91%
Return on assets
-11.08%
Return on sales
0%
Return on invested capital
146.66%
Total debt ratio
11.73%
Debt ratio change over time
-0.92%
Current Ratio
9.55%
Quick Ratio
0%
Cash Position Ratio
9.49%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-89.76%
Return on assets
-110.45%
Return on sales
0%
Return on invested capital
-68.02%
Total debt ratio
-81.25%
Debt ratio change over time
-0.81%
Current Ratio
0.26%
Quick Ratio
0%
Cash Position Ratio
0.14%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | LPTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -17.81% | -3.05% | 11.55% | 6.27% |
| Return on assets | -38.97% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 180.11% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 37% | 68% | 60% |
| Total debt ratio | 50.6% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.81% | 6.09% | 6.03% | 1.53% |
| Dept financing | 13% | 50% | 43% | 14% |
| Current Ratio | 3.81% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 3.74% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 25% | 51% | 54% |
| Short-term ratios | LPTX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 101.2% | -25.62% | 17.94% | 7.14% |
| Return on assets | -59.39% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 154.36% | 8.14% | 7.17% | 18.16% |
| Profitability | 50% | 39% | 50% | 52% |
| Total debt ratio | 65.29% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.6% | -23.44% | 9.66% | 0.6% |
| Dept financing | 15% | 25% | 45% | 8% |
| Current Ratio | 3.81% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 3.74% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 41% | 33% | 58% |